Safety and the Efficacy of MesenCure for the Treatment of Pulmonary Manifestations of COVID-19
Clinical trial NCT04716998 · COMPLETED
Trial details
- NCT number
- NCT04716998
- Sponsor
- BonusBio Group Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-14
- Primary completion
- 2022-01-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.